← Leaderboards
Karen T Chang
Trustees Of Indiana University
$10,309,480
Attributed
$12,625,763
Total exposure
7
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.4M · FY2007–25$5M$3.8M$2.5M$1.3M$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$12,625,763 · 7
By mechanism
R01$8,552,595 · 3
RF1$2,792,837 · 1
R00$737,331 · 1
R21$363,000 · 1
K99$180,000 · 1
Top collaborators
- Jeannie Chen4 shared
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposS DiseaseMolecularDrosophila GenusNervous System DisorderGeneticNeuronsProteinsAffectPhysiologicalInsightSynapsesIn VivoMediatingBrainDown SyndromeGrowthNervous System StructureNew Therapeutic TargetNeuromuscular JunctionExperimental StudyLearningPathway InteractionsMemory
Grant awards (27)
Role of DYRK1A/MNB in synaptic growth and function$502,735
R01 · FY2025 · NS · contact PI
Role of DYRK1A/MNB in synaptic growth and function$437,707
R01 · FY2022 · NS · contact PI
Molecular mechanisms underlying activity-induced synaptic remodeling$436,541
R01 · FY2022 · NS · contact PI
Peripheral TGF-beta Pathway Inhibitor Therapy in Alzheimer's Rats$607,173
R01 · FY2021 · NS
Role of DYRK1A/MNB in synaptic growth and function$437,707
R01 · FY2021 · NS · contact PI
Molecular mechanisms underlying activity-induced synaptic remodeling$436,541
R01 · FY2021 · NS · contact PI
Peripheral TGF-beta Pathway Inhibitor Therapy in Alzheimer's Rats$618,808
R01 · FY2020 · NS
Role of DYRK1A/MNB in synaptic growth and function$442,345
R01 · FY2020 · NS · contact PI
Molecular mechanisms underlying activity-induced synaptic remodeling$436,541
R01 · FY2020 · NS · contact PI
Peripheral TGF-beta Pathway Inhibitor Therapy in Alzheimer's Rats$613,749
R01 · FY2019 · NS
Role of DYRK1A/MNB in synaptic growth and function$443,152
R01 · FY2019 · NS · contact PI
Molecular mechanisms underlying activity-induced synaptic remodeling$439,263
R01 · FY2019 · NS · contact PI
Role of DYRK1A/MNB in synaptic growth and function$453,361
R01 · FY2018 · NS · contact PI
Molecular mechanisms underlying activity-induced synaptic remodeling$449,163
R01 · FY2018 · NS · contact PI
(PQ#9): Altered mitochondrial transport and chemotherapy-induced peripheral neuropathy$165,000
R21 · FY2018 · CA · contact PI
Innate Immune IL-10/STAT3 Signaling in Alzheimer's Disease$2,792,837
RF1 · FY2017 · AG
Role of DYRK1A/MNB in Synaptic growth and function$360,938
R01 · FY2017 · NS · contact PI
(PQ#9): Altered mitochondrial transport and chemotherapy-induced peripheral neuropathy$198,000
R21 · FY2017 · CA · contact PI
Role of DYRK1A/MNB in Synaptic growth and function$360,938
R01 · FY2016 · NS · contact PI
Role of DYRK1A/MNB in Synaptic growth and function$360,938
R01 · FY2015 · NS · contact PI
Role of DYRK1A/MNB in Synaptic growth and function$356,245
R01 · FY2014 · NS · contact PI
Role of DYRK1A/MNB in Synaptic growth and function$358,750
R01 · FY2013 · NS · contact PI
Role of nebula/DSCR1 in mitochondria$239,331
R00 · FY2011 · NS · contact PI
Role of nebula/DSCR1 in mitochondria$249,000
R00 · FY2010 · NS · contact PI
Role of nebula/DSCR1 in mitochondria$249,000
R00 · FY2009 · NS · contact PI
Role of nebula/DSCR1 in mitochondria$90,000
K99 · FY2008 · NS · contact PI
Role of nebula/DSCR1 in mitochondria$90,000
K99 · FY2007 · NS · contact PI